After reviewing the information presented in the Case Study, including the direct illustration of the results/incidents stemming from failure in Quality Assurance protocols surrounding the Therac-25 development effort, please address the following questions. Reference the Therac-25 case study where applicable. Each answer should be no more than two to three paragraphs.

How might design choices and QA practices differ from safety-critical systems where lives are potentially on the line?